Blood lipids. Data source Internal provider sample submitted to National Audit provider for the CQUIN. Frequency of data collection Data for national audit expected to be collected and submitted to national audit provider during Quarter 3 of 2016/17 – results to be available in Quarter 4 Organisation responsible for data collection MH Provider Frequency of reporting to commissioner Results of national expected to be available for Quarter 4 for reporting to commissioners (April 2017). Additional direct reporting to commissioners locally in Quarters 2, 3 and 4. Baseline period/date Not applicable Baseline Not applicable Final indicator period/date (on which payment is based) Quarter 4, 2016/17 indicator value (payment threshold) Inpatients – 90% Early Intervention Psychosis Services – 90% Community Mental Health Services (Patients on CPA) - 65% Rules for calculation of payment due at final indicator period/date (including evidence to be supplied to commissioner) Quarter 4 audit results demonstrate that for 90% of inpatients, 90% of Early Intervention Psychosis services and 65% of Community Mental Health Services audited, the provider has undertaken an assessment of each of the cardio metabolic parameters below, with the results recorded in the patient's records/care plan/discharge documentation as appropriate, together with a record of associated interventions where indicated (eg smoking cessation programme, lifestyle interventions, medication review, treatment
55.0% to 64.9% 75% payment 65.0% or above 100% payment Supporting Guidance and References ICD 10 codes: For the purposes of the CQUIN, patients who have a diagnosis of psychosis, including schizophrenia and bipolar affective disorder with the relevant ICD-10 diagnostic codes will be included in the national audit: F10.5, F11.5, F12.5, F13.5, F14.5, F15.5, F16.5, F19.5, F20-29, F30.2, F31.2, F31.5, F32.3 and F33.3 Lester tool: http://www.rcpsych.ac.uk/pdf/eversion%20NICE%20Endorsed%20Lester%20UK%20adaptation%20.pdf 3b. Communication with General Practitioners Indicator Indicator name Communication with General Practitioners Indicator weighting (% of scheme available) 20% of 0.25% (0.05%) Description of indicator 90% of patients to have either an updated CPA ie a care programme approach care plan or a comprehensive discharge summary shared with the GP. A local audit of communications should be completed.
Indicator name Reduction in antibiotic consumption per 1,000 admissions Indicator weighting (% of CQUIN scheme available) 80% of 0.25% (0.20%) Description of indicator There are three parts to this indicator. Total antibiotic consumption per 1,000 admissions Total consumption of carbapenem per 1,000 admissions Total consumption of piperacillin-tazobactam per 1,000 admissions Numerator Total antibiotic consumption as measured by Defined Daily Dose (DDD) Total consumption of carbapenem as measured by Defined Daily Dose (DDD) Total consumption of piperacillin-tazobactam as measured by Defined Daily Dose (DDD) Denominator admissions divided by 1,000 Rationale for inclusion Antimicrobial resistance (AMR) has risen alarmingly over the last 40 years and inappropriate and overuse of antimicrobials is a key driver. The number of new classes of antimicrobials coming to the market has reduced in recent years and between 2010 and 2013, total antibiotic prescribing in England increased by 6%. This leaves the prospect of reduced treatment options when antimicrobials are life-saving and standard surgical procedures could become riskier with widespread antimicrobial resistance. An AMR aims to reduce total antibiotic consumption measured as defined daily doses (DDDs) per 1000 admissions as well as to obtain evidence of antibiotic review within 72 hours of commencing an antibiotic. The CQUIN has two parts, the first aimed at reducing total antibiotic consumption and certain broad-spectrum antibiotics and the second focussed on antimicrobial stewardship and ensuring antibiotic review within 72 hours.